Is 4-HO-MET (Metocin) Legal in Louisiana? (2026)

Instrument

Composition of schedules -- Schedule I, Subsection C (Hallucinogenic substances)

Source

https://legis.la.gov/Legis/LawPrint.aspx?d=98877

Retrieved

2026-07-20

Fingerprint

eb5d62d71e9fbd1b

C. Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, or salts of isomers, whenever the existence of such salts, isomers, or salts of isomers is possible within the specific chemical designation, for purposes of this Subsection only, the term "isomer" includes the optical, position, and geometric isomers: (1) Alpha-ethyltryptamine (2) Alphamethyltryptamine (3) 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB) (4) 6-(2-aminopropyl)-2,3-dihydrobenzofuran (6-APDB) (5) 5-(2-aminopropyl)benzofuran (5-APB) (6) 6-(2-aminopropyl)benzofuran (6-APB) (7) 4-bromo-2,5-dimethoxyamphetamine (8) 4-bromo-2,5-dimethoxyphenethylamine (9) 4-bromo-2,5-dimethoxyphenethylamine (2C-B) (10) Bufotenine (11) 4-chloro-2,5-dimethoxyamphetamine (12) Deschloroketamine (2-phenyl-2(methylamino) cyclohexanone) (13) Deschloro-N-ethyl-ketamine (2-(ethylamino)-2-phenylcyclohexan-1-one) (14) Diethyltryptamine (15) Diisopropyltryptamine (DIPT) (16) 2,5-dimethoxy-4-chlorophenethylamine (2C-C) (17) 2,5-dimethoxy-4-ethylamphetamine (18) 2,5-dimethoxy-4-ethylphenethylamine (2C-E) (19) 2,5-dimethoxy-4-ethylthiophenethylamine (2C-T-2) (20) 2,5-dimethoxy-4-iodophenethylamine (2C-I) (21) 2,5-dimethoxy-4-isopropylthiophenethylamine (2C-T-4) (22) 2,5-dimethoxy-4-methylphenethylamine (2C-D) (23) 2,5-dimethoxy-4-methylthiophenethylamine (2C-T) (24) 2,5-dimethoxy-4-nitrophenethylamine (2C-N) (25) 2,5-dimethoxy-4-(n)-propylphenethylamine (2C-P) (26) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (27) 2,5-dimethoxyamphetamine (28) 2,5-dimethoxyphenethylamine (2C-H) (29) Dimethyltryptamine (30) Ethylamine analog of phencyclidine (31) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone (Methoxetamine) (32) 4-Fluoroamphetamine (4-FA) (33) 4-Fluoromethamphetamine (4-FMA) (34) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DIPT) (35) 4-hydroxy-N-methyl-N-isopropyltryptamine (4-Hydroxy-MIPT) (36) Ibogaine (37) 5-iodo-2-aminoindane (5-IAI) (38) 4-iodo-2,5-dimethoxyamphetamine (39) Lysergic acid diethylamide (40) Marihuana (41) Mescaline (42) 5-methoxy-alpha-methyltryptamine (5-MEO-AMT) (43) 4-methoxyamphetamine (44) 5-methoxy-3,4-methylenedioxyamphetamine (45) 5-methoxy-N,N-diallyl-tryptamine (5-MEO-DALT) (46) 5-methoxy-N,N-diethyltryptamine (5-MEO-DET) (47) 5-methoxy-N, N-diisopropyltryptamine (48) 5-methoxy-N,N-dimethyltryptamine (5-MEO-DMT) (49) 5-methoxy-N-methyl-N-isopropyltryptamine (5-MEO-MIPT) (50) 4-methyl-2,5-dimethoxyamphetamine (51) 5-(2-methylaminopropyl)benzofuran (5-MAPB) (52) 5,6-methylenedioxy-2-aminoindane (MDAI) (53) 3,4-methylenedioxyamphetamine (54) 3,4-methylenedioxymethamphetamine (MDMA) (55) 3,4-methylenedioxy-N-ethylamphetamine (56) N-ethyl-3-piperidyl benzilate (57) N-hydroxy-3,4-methylenedioxyamphetamine (58) N-(2-hydroxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOH) (59) N-(2-methoxybenzyl)-2,5-dimethoxy-4-bromophenethylamine (25B-NBOMe) (60) N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) (61) N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (25I-NBOMe) (62) N-methyl-3-piperidyl benzilate (63) Parahexyl, also known as Synhexyl (64) para-methoxymethamphetamine (PMMA) (65) Peyote (66) Psilocybin (67) Psilocyn (68) Pyrrolidine analog of phencyclidine (69) Tetrahydrocannabinols, including synthetic equivalents and derivatives, except for tetrahydrocannabinols in hemp (70) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (71) Thiophene analog of phencyclidine (72) 3,4,5-trimethoxy amphetamine

Instrument

statute

Source

https://legis.la.gov/legis/Law.aspx?d=98877

Retrieved

2026-06-19

Fingerprint

565c81187a45f314

**§ 40:964 Schedule I(C) header** "C. Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of their salts, isomers, or salts of isomers, whenever the existence of such salts, isomers, or salts of isomers is possible within the specific chemical designation, for purposes of this Subsection only, the term 'isomer' includes the optical, position, and geometric isomers:"
— La. R.S. 40:964(C), https://legis.la.gov/legis/Law.aspx?d=98877 (official Louisiana State Legislature)
**Nearest listed entries — neither is 4-HO-MET:** "(34) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DIPT)" and "(35) 4-hydroxy-N-methyl-N-isopropyltryptamine (4-Hydroxy-MIPT)." 4-HO-MET (the N-ethyl homolog) is absent.
— La. R.S. 40:964(C), same URL
**Analog act — La. R.S. 40:961(9):** "'Controlled substance analogue' means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled dangerous substance in Schedule I or II of R.S. 40:964; which has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than … a controlled dangerous substance in Schedule I or II; or with respect to a particular person, which such person represents or intends to have [such effect] … Such term shall not include … any substance to the extent not intended for human consumption …"
— La. R.S. 40:961(9); via labeled Justia mirror (2025 Louisiana Laws), full section read: https://law.justia.com/codes/louisiana/revised-statutes/title-40/rs-40-961/

Instrument

Unlawful production, manufacturing, distribution, or possession of prohibited plant products; exceptions

Source

https://legis.la.gov/legis/LawPrint.aspx?d=726196

Retrieved

2026-10-07

Fingerprint

81397db085d61af0

§989.2. Unlawful production, manufacturing, distribution, or possession of prohibited plant products; exceptions A.(1) It shall be unlawful for any person knowingly or intentionally to produce, manufacture, distribute, or possess with intent to produce, manufacture, or distribute a material, compound, mixture, or preparation which contains a prohibited plant and which meets any of the following criteria: (a) It is intended to be placed in the oral or nasal cavity. (b) It is prepared in such a manner as to be suitable for smoking in a pipe or cigarette, or other device. (c) It is to be burned and inhaled or exhaled in any manner or in any form. (2) Whoever violates the provisions of this Subsection shall be sentenced to a term of imprisonment with or without hard labor for not more than five years and may, in addition, be sentenced to pay a fine of not more than ten thousand dollars. B.(1) It shall be unlawful for any person knowingly or intentionally to possess material, compound, mixture, or preparation which contains a prohibited plant and which is intended to be placed in the oral or nasal cavity, is prepared in such a manner as to be suitable for smoking in a pipe or cigarette, or is to be burned and inhaled or exhaled in any manner or in any form. (2) Any person who violates the provisions of this Subsection shall be fined not more than five hundred dollars, imprisoned for not more than six months, or both. C. For the purposes of this Section: (1) "Distribute" means to sell, barter, trade, furnish, supply, or otherwise transfer in exchange for anything of value a material, compound, mixture, or preparation which contains a prohibited plant. (2) "Homeopathic drug" means any drug labeled as being homeopathic which is listed in the Homeopathic Pharmacopoeia of the United States, an addendum to it, or its supplements. The potencies of homeopathic drugs are specified in terms of dilution. Homeopathic drug products must contain diluents commonly used in homeopathic pharmaceutics. Drug products containing homeopathic ingredients in combination with non-homeopathic active ingredients are not homeopathic drug products. (3) "Manufacture" means the production, preparation, propagation, compounding, or processing of a material, compound, mixture, or preparation which contains a prohibited plant either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis. Manufacturer includes any person who packages, repackages, or labels any container holding a material, compound, mixture, or preparation which contains a prohibited plant. (4) "Production" includes the manufacture, planting, cultivation, growing, or harvesting of a prohibited plant. (5) "Prohibited plant" means any combination of any of the parts, leaves, stems, stalks, seeds, materials, compounds, salts, derivatives, mixtures, preparations, or any resin extracted from any part of the following plants: (a) Artemisia vulgaris (Mugwort). (b) Canavalia rosea (Bay bean). (c) Leonotis leonurus (Lion's tail). (d) Leonotis nepetifolia (Lion's ear). (e) Leonurus sibiricus (Honeyweed). (f) Mitragyna speciosa. (g) Nelumbo nucifera (Sacred Lotus). (h) Nymphaea caerulea (Blue Lotus, Egyptian Lotus). (i) Pedicularis densiflora (Indian warrior). (j) Salvia divinorum. (k) Scutellaria nana (Dwarf skullcap). (l) Turnera diffusa (Damiana). (m) Zornia latifolia. D. The provisions of this Section shall not apply to any dosage form which is legally obtainable from a retail establishment without a prescription and is recognized by the United States Food and Drug Administration as a homeopathic drug. E. The provisions of this Section shall not apply to the possession, planting, cultivation, growing, or harvesting of a prohibited plant strictly for aesthetic, landscaping, or decorative purposes. F. The provisions of this Section shall not apply to any dosage form which is labeled as a dietary supplement and is manufactured in compliance with the requirements of sections 402(g)(2), 415, and 761 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 342(g)(2), 350d, and 379aa-1). Acts 2010, No. 565, §1; Acts 2015, No. 373, §1, eff. July 1, 2015; Acts 2018, No. 206, §4; Acts 2025, No. 41, §1.